Endo International PLC (USD)
ENDP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range4.79 | 5.76
52-Wk Range1.97 | 12.49
Last Close4.82
Mkt Cap (m)1,093.06
Dividend yield-
ISINIE00BJ3V9050
Volume47
Exchange VenueNAS

Company Profile

Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales0.37
P/CF5.73
Rev Growth (3 year avg)-3.39
EPS Growth (3 year avg)-
Operating Margin % 16.41
Net Margin %-35.00
Return on Equity-
Debt/Equity-

Legal Documents

Prospectus
en 08/08/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)2,6172,8773,2694,0103,4692,947
Operating Income (m)586527350421438484
Net Income (m)-685-721-1,495-3,347-2,035-1,031
Basic EPS-6.05-4.91-7.59-15.03-9.12-4.61
Avg. Diluted Shares Outstanding (m)113147197223223224
Balance Sheet
USD201320142015201620172018
Current Assets (m)2,8553,3073,4752,5892,2712,343
Non Current Assets (m)3,7177,60215,87511,6869,3657,789
Total Assets (m)6,57210,91019,35014,27511,63610,132
Current Liabilities (m)1,6973,0993,4742,6352,2211,950
Total Liabilities (m)------
Total Equity (m)5262,3755,9682,702485-498
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)29933862524554267
Capital Expenditure (m)-108-85-126-158-126-86
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
4.82
Last Price